CHAMPIONX CORP (CHX) Stock Fundamental Analysis

NASDAQ:CHX • US15872M1045

25.81 USD
-0.79 (-2.97%)
At close: Jul 15, 2025
25.83 USD
+0.02 (+0.08%)
After Hours: 7/15/2025, 8:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CHX. CHX was compared to 60 industry peers in the Energy Equipment & Services industry. CHX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CHX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CHX was profitable.
  • CHX had a positive operating cash flow in the past year.
  • Of the past 5 years CHX 4 years were profitable.
  • CHX had a positive operating cash flow in each of the past 5 years.
CHX Yearly Net Income VS EBIT VS OCF VS FCFCHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

  • CHX has a Return On Assets of 8.37%. This is in the better half of the industry: CHX outperforms 79.03% of its industry peers.
  • With a decent Return On Equity value of 15.29%, CHX is doing good in the industry, outperforming 77.42% of the companies in the same industry.
  • CHX has a Return On Invested Capital of 14.15%. This is amongst the best in the industry. CHX outperforms 88.71% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CHX is in line with the industry average of 12.98%.
  • The last Return On Invested Capital (14.15%) for CHX is above the 3 year average (13.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROIC 14.15%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
CHX Yearly ROA, ROE, ROICCHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • The Profit Margin of CHX (8.20%) is better than 66.13% of its industry peers.
  • CHX's Profit Margin has improved in the last couple of years.
  • CHX has a better Operating Margin (14.41%) than 72.58% of its industry peers.
  • In the last couple of years the Operating Margin of CHX has grown nicely.
  • CHX has a Gross Margin of 33.16%. This is in the better half of the industry: CHX outperforms 62.90% of its industry peers.
  • CHX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
CHX Yearly Profit, Operating, Gross MarginsCHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

8

2. Health

2.1 Basic Checks

  • CHX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CHX has less shares outstanding than it did 1 year ago.
  • CHX has more shares outstanding than it did 5 years ago.
  • CHX has a better debt/assets ratio than last year.
CHX Yearly Shares OutstandingCHX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CHX Yearly Total Debt VS Total AssetsCHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • CHX has an Altman-Z score of 3.65. This indicates that CHX is financially healthy and has little risk of bankruptcy at the moment.
  • CHX has a Altman-Z score of 3.65. This is amongst the best in the industry. CHX outperforms 85.48% of its industry peers.
  • The Debt to FCF ratio of CHX is 1.74, which is an excellent value as it means it would take CHX, only 1.74 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CHX (1.74) is better than 80.65% of its industry peers.
  • CHX has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • CHX has a Debt to Equity ratio of 0.31. This is in the better half of the industry: CHX outperforms 61.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Altman-Z 3.65
ROIC/WACC1.51
WACC9.37%
CHX Yearly LT Debt VS Equity VS FCFCHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

  • CHX has a Current Ratio of 2.25. This indicates that CHX is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.25, CHX is doing good in the industry, outperforming 67.74% of the companies in the same industry.
  • CHX has a Quick Ratio of 1.62. This is a normal value and indicates that CHX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.62, CHX is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.62
CHX Yearly Current Assets VS Current LiabilitesCHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

  • CHX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.63%.
  • Measured over the past years, CHX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.09% on average per year.
  • The Revenue has decreased by -4.17% in the past year.
  • Measured over the past years, CHX shows a very strong growth in Revenue. The Revenue has been growing by 26.29% on average per year.
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%

3.2 Future

  • CHX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.80% yearly.
  • CHX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.82% yearly.
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHX Yearly Revenue VS EstimatesCHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
CHX Yearly EPS VS EstimatesCHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

  • CHX is valuated correctly with a Price/Earnings ratio of 14.26.
  • Compared to the rest of the industry, the Price/Earnings ratio of CHX indicates a somewhat cheap valuation: CHX is cheaper than 64.52% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.67. CHX is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 13.24 indicates a correct valuation of CHX.
  • CHX's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.69, CHX is valued rather cheaply.
Industry RankSector Rank
PE 14.26
Fwd PE 13.24
CHX Price Earnings VS Forward Price EarningsCHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • CHX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • CHX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 14.43
EV/EBITDA 6.58
CHX Per share dataCHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CHX does not grow enough to justify the current Price/Earnings ratio.
  • CHX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.24
PEG (5Y)1.29
EPS Next 2Y3.8%
EPS Next 3Y5.08%

3

5. Dividend

5.1 Amount

  • CHX has a Yearly Dividend Yield of 1.47%.
  • CHX's Dividend Yield is a higher than the industry average which is at 1.13.
  • Compared to an average S&P500 Dividend Yield of 1.80, CHX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.47%

5.2 History

  • The dividend of CHX decreases each year by -47.78%.
  • CHX has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)-47.78%
Div Incr Years2
Div Non Decr Years2
CHX Yearly Dividends per shareCHX Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

  • 24.70% of the earnings are spent on dividend by CHX. This is a low number and sustainable payout ratio.
DP24.7%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
CHX Yearly Income VS Free CF VS DividendCHX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
CHX Dividend Payout.CHX Dividend Payout, showing the Payout Ratio.CHX Dividend Payout.PayoutRetained Earnings

CHAMPIONX CORP

NASDAQ:CHX (7/15/2025, 8:00:00 PM)

After market: 25.83 +0.02 (+0.08%)

25.81

-0.79 (-2.97%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-18
Earnings (Next)10-21
Inst Owners95.44%
Inst Owner Change-65.76%
Ins Owners0.99%
Ins Owner Change0%
Market Cap4.94B
Revenue(TTM)3.58B
Net Income(TTM)293.14M
Analysts86.67
Price Target42.23 (63.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.47%
Yearly Dividend0.37
Dividend Growth(5Y)-47.78%
DP24.7%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)0.36%
Max EPS beat(2)14.53%
EPS beat(4)2
Avg EPS beat(4)-2.36%
Min EPS beat(4)-19.69%
Max EPS beat(4)14.53%
EPS beat(8)4
Avg EPS beat(8)0.56%
EPS beat(12)8
Avg EPS beat(12)1.75%
EPS beat(16)11
Avg EPS beat(16)1.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-1.16%
Revenue beat(4)0
Avg Revenue beat(4)-4.29%
Min Revenue beat(4)-7.8%
Max Revenue beat(4)-1.16%
Revenue beat(8)0
Avg Revenue beat(8)-3.77%
Revenue beat(12)2
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)-1.9%
EPS NQ rev (1m)-2.98%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)-6.47%
EPS NY rev (3m)-10.47%
Revenue NQ rev (1m)-1.62%
Revenue NQ rev (3m)-4.6%
Revenue NY rev (1m)-2.24%
Revenue NY rev (3m)-7.4%
Valuation
Industry RankSector Rank
PE 14.26
Fwd PE 13.24
P/S 1.38
P/FCF 14.43
P/OCF 10.23
P/B 2.58
P/tB 4.71
EV/EBITDA 6.58
EPS(TTM)1.81
EY7.01%
EPS(NY)1.95
Fwd EY7.56%
FCF(TTM)1.79
FCFY6.93%
OCF(TTM)2.52
OCFY9.77%
SpS18.68
BVpS10.01
TBVpS5.48
PEG (NY)2.24
PEG (5Y)1.29
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROCE 18.98%
ROIC 14.15%
ROICexc 17.55%
ROICexgc 29.07%
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
FCFM 9.57%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
ROICexc(3y)15.86%
ROICexc(5y)10.93%
ROICexgc(3y)28.04%
ROICexgc(5y)19.36%
ROCE(3y)18.31%
ROCE(5y)12.72%
ROICexgc growth 3Y47.18%
ROICexgc growth 5Y16.9%
ROICexc growth 3Y46.83%
ROICexc growth 5Y30.42%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Debt/EBITDA 0.78
Cap/Depr 57.1%
Cap/Sales 3.93%
Interest Coverage 250
Cash Conversion 63.4%
Profit Quality 116.78%
Current Ratio 2.25
Quick Ratio 1.62
Altman-Z 3.65
F-Score6
WACC9.37%
ROIC/WACC1.51
Cap/Depr(3y)53.43%
Cap/Depr(5y)43.4%
Cap/Sales(3y)3.46%
Cap/Sales(5y)3.1%
Profit Quality(3y)155.68%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%
EBIT growth 1Y0.17%
EBIT growth 3Y40.57%
EBIT growth 5Y37.22%
EBIT Next Year52.58%
EBIT Next 3Y14.47%
EBIT Next 5Y9.48%
FCF growth 1Y-23.96%
FCF growth 3Y22.54%
FCF growth 5Y31.03%
OCF growth 1Y-12.01%
OCF growth 3Y21.57%
OCF growth 5Y30.48%

CHAMPIONX CORP / CHX FAQ

What is the ChartMill fundamental rating of CHAMPIONX CORP (CHX) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CHX.


Can you provide the valuation status for CHAMPIONX CORP?

ChartMill assigns a valuation rating of 4 / 10 to CHAMPIONX CORP (CHX). This can be considered as Fairly Valued.


What is the profitability of CHX stock?

CHAMPIONX CORP (CHX) has a profitability rating of 8 / 10.


Can you provide the expected EPS growth for CHX stock?

The Earnings per Share (EPS) of CHAMPIONX CORP (CHX) is expected to grow by 6.36% in the next year.


Is the dividend of CHAMPIONX CORP sustainable?

The dividend rating of CHAMPIONX CORP (CHX) is 3 / 10 and the dividend payout ratio is 24.7%.